TargED Biopharmaceuticals, a biotech spin-off of the University Medical Center Utrecht founded by Associate prof. Coen Maas, PhD, Steven de Maat, PhD, Marc van Moorsel and Kristof Vercruysse, raised ...
UTRECHT, Netherlands & AMSTERDAM--(BUSINESS WIRE)--UMC Utrecht has enrolled its first patient for a new study to identify biomarkers of Amyotrophic Lateral Sclerosis (ALS). The observational ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Research at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the ...
UMC Utrecht researchers in the Netherlands are starting two new projects to treat cancer with image-guided interventions. For one research project, they are using MRI-guided radiotherapy, for the ...
Collaboration to highlight impact of cutting-edge artificial intelligence applications in routine, high-throughput pathology workflows PHILADELPHIA & UTRECHT, Netherlands–(BUSINESS WIRE)–Proscia®, a ...
Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal ...
The University Medical Center (UMC) Utrecht, Netherlands, has announced that it has enrolled its first patient in a new study to identify biomarkers of amyotrophic lateral sclerosis (ALS), in ...
The positions in the table below reflect the University Medical Center Utrecht (UMC Utrecht)'s position overall, domestically, within their sector, and in various subject areas based on their Share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results